EUVIMEDAtrasti EUVIMED
Leserbrief

Beyond baseline inflammation: Exploring dynamic prognostication with longitudinal laboratory profiles and circulating tumour DNA during EGFR blockade in metastatic colorectal cancer

Shuyi Song, Jinmin Han, Yu Wang, Shulun Nie iD

Colorectal Disease · 2026-11 · 28 (11)

DOI: 10.1111/codi.70687 ↗

At a glance

Leserbrief in Colorectal Disease, published online on 2026-11-16. Written by Shuyi Song and 3 co-authors. Institution: Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China. 5 references.

SantraukaBibliografiniai duomenysCiteRelated studies

Abstract (original language)

Data sharing is not applicable to this article, as no datasets were generated or analysed during the current work.

Authors and institutions

  • Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
  • Department of Radiotherapy, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong, China.
  • Department of Transfusion Medicine, Key Laboratory of Jiangxi Province for Transfusion Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.

ORCID profiles: Shulun Nie

Cite

APA

Song, S., Han, J., Wang, Y., & Nie, S. (2026). Beyond baseline inflammation: Exploring dynamic prognostication with longitudinal laboratory profiles and circulating tumour DNA during EGFR blockade in metastatic colorectal cancer. Colorectal Disease, 28(11). https://doi.org/10.1111/codi.70687

Vancouver

Song S, Han J, Wang Y, Nie S. Beyond baseline inflammation: Exploring dynamic prognostication with longitudinal laboratory profiles and circulating tumour DNA during EGFR blockade in metastatic colorectal cancer. Colorectal Disease. 2026;28(11). doi:10.1111/codi.70687

BibTeX
@article{Song2026,
  author = {Song, Shuyi and Han, Jinmin and Wang, Yu and Nie, Shulun},
  title = {Beyond baseline inflammation: Exploring dynamic prognostication with longitudinal laboratory profiles and circulating tumour DNA during EGFR blockade in metastatic colorectal cancer},
  journal = {Colorectal Disease},
  year = {2026},
  volume = {28},
  number = {11},
  doi = {10.1111/codi.70687}
}
Start for free →